ADA 2020: Medtronic Explains Strategy To Return Growth To Diabetes Business
Medtronic will launch its next-generation MiniMed 780G insulin pump while continuing to develop complementary technologies to close the competitive gap with its rivals in the diabetes market.
You may also be interested in...
The company’s revenue was down just 1% year-over-year in the third quarter of fiscal 2021, despite the ongoing impact of the pandemic.
Sean Salmon, the head of Medtronic’s diabetes business, will take over the leadership of the company’s cardiovascular business effective 1 January.
The medtech giant will simplify its organizational structure, consolidate operations and give more autonomy to its individual operating units.